1. Introduction
Phenylbutazone (PBZ) (
Figure 1), first introduced in 1949, has been used in human medicine to manage acute and chronic inflammatory pain, especially in different forms of arthritis. It has been used as a first-line therapeutic option in the treatment of arthritis for three decades. PBZ is a nonsteroidal anti-inflammatory drug (NSAID). The first pharmaceutical product with PBZ had an initial recommended dosage of 400–600 mg/day, divided into multiple doses; later, the recommended dosage was reduced to 200–300 mg/day, with maximum recommended doses up to 1 g/day [
1]. The half-life of PBZ ranges from 50 to 105 h, this variation depending on genetics, dose, and time of administration. After oral administration, it is largely absorbed into plasma and binds mainly to albumin, while 10% of the drug is converted to metabolites in the bile and approximately 1% of PBZ is eliminated renally [
2]. The use of PBZ is associated with common adverse reactions such as skin rash, edema, nausea, and gastrointestinal problems (peptic ulcer, stomatitis), as well as severe hematological complications, including anemia, leukopenia, thrombocytopenia, and agranulocytosis [
3,
4]. The administration of high doses, especially those that reached or exceeded 1600 mg daily, was largely correlated with severe adverse effects. Such elevated doses were administered at the time, which led to a very high incidence of severe adverse reactions and highlighted the need for rigorous dose control and treatment monitoring [
3,
4]. PBZ began to be withdrawn from the market in the USA in the 1980s, but that did not stop the drug from being used in veterinary medicine, especially for dogs and horses [
1]. Even so, the continued availability of PBZ in topical forms in different European countries (e.g., Romania) increases the risk of environmental leaching and accidental human exposure, requiring sensitive detection methods to monitor compliance with international health bans. Also, its use in veterinary medicine poses a persistent risk of accidental entry into the human food supply chain [
5], and in the environment, where its stability and slow degradation lead to the contamination of soil and aquatic ecosystems, potentially affecting non-target species [
6]. Considering that PBZ remains in use, despite significant adverse reactions, there is a need to develop an efficient method for its detection in pharmaceutical products and biological fluids.
In the literature, a variety of advanced techniques have been used for the detection of PBZ. Among the most common techniques are chromatographic techniques (thin-layer chromatography—TLC [
7], liquid chromatography coupled with mass spectrometry, LC-MS/MS [
8], high-performance liquid chromatography—HPLC [
9,
10,
11], gas chromatography—GC [
12], which is often coupled with mass spectrometry—GC-MS [
13]) and spectrometric techniques (IR spectrometry [
14], UV-Vis spectroscopy [
15]). Usually, these classical methods have very good accuracy, but they are usually expensive, laborious, and time-consuming and involve complex sample preparation processes with relatively high consumption of reagents and solvents. An appropriate analytical approach to overcome these issues involves the use of electrochemical sensors, as they require minimal sample preparation and enable rapid and accurate analysis. Electrochemical techniques have emerged as valuable tools in drug analysis, largely due to their simplicity, rapid analysis time, and lower cost compared to other methods [
16]. These techniques offer a viable alternative to other instrumental methods, demonstrating considerable efficiency in detecting PBZ in different types of samples. A series of electrochemical sensors for PBZ detection has been reported in the scientific literature (
Table 1).
Although recently developed voltammetric sensors have achieved low detection limits for PBZ, most still face challenges related to their applicability in real samples, including matrix interferences and signal instability under variable experimental conditions. To address these limitations, this study introduces commercially available screen-printed electrodes (SPEs) modified with transition metal particles, used here for the first time to catalyze the response.
The primary objective is to develop a rapid and reliable electroanalytical method for the selective and sensitive determination of PBZ in complex matrices. SPEs are widely used due to their simple fabrication process [
19], low production cost, ease of use, and excellent reproducibility.
Carbon-based screen-printed electrodes (CSPEs) are particularly versatile owing to the diverse carbon inks available for screen-printing and the numerous possibilities for surface modification [
20]. Transitional metals such as rhodium, palladium, platinum, and iridium are successfully used for the manufacture of modified SPEs for the detection of various organic compounds due to their favourable physicochemical properties, such as high melting point, corrosion resistance, and excellent conductivity, but also due to their stability in electrochemical processes and high catalytic activity [
21]. These features make metal particle-modified SPEs a feasible alternative to fabricate devices with high detection limits, high sensitivity, high electrode surface resistance, as well as high reproducibility [
22,
23,
24,
25,
26], properties necessary for chemically modified electrochemical sensors to be an alternative to conventional analysis methods.
The approach proposed in this work was to detect PBZ involving a catechol-mediated electrooxidation process. Catechol can be oxidized electrochemically to o-quinone, and the o-quinone can participate in a coupling reaction with different nucleophilic compounds to form a C–C or C–O bond [
27]. o-Quinone is a reactive intermediary compound, which acts as a Michael acceptor to react with several nucleophilic compounds [
28,
29]. This type of reaction could be taking place because PBZ is a nucleophilic compound [
30]. The electrochemical process of the adduct formed between catechol and PBZ could be facilitated by the presence of metallic particles on the SPE surface [
31,
32]. The modalities of electrochemical process enhancement include increasing the active surface area, facilitating electron transfer, and catalytic effects [
33,
34,
35]. The catechol was selected as a redox probe due to its susceptibility to oxidation, which is related to its antioxidant properties. The electro-oxidation process results in the formation of o-quinone, which is reactive and electron-deficient, and it can act as a reactive species in different chemical reactions with nucleophilic compounds such as cycloheptylamine, aniline, sulfanilic acid, phenyl-Meldrum’s acid, 2-thiobarbituric acid, proline, etc. [
29].
The catechol exhibits rapid charge transfer kinetics; the redox process involves the transfer of two electrons and two protons, providing a robust signal, and it allows amplification of currents through redox cycling processes, providing increased sensitivity for analyte detection [
36,
37].
In this paper, a novel application of CSPEs modified with rhodium, palladium, platinum, or iridium particles for PBZ detection is presented. The novelty of this work also consists of the use of catechol as a redox probe, which facilitates the redox process of PBZ and increases the sensitivity. To the best of our knowledge, there are no studies on the electrochemical oxidation of catechol in the presence of PBZ.
2. Materials and Methods
All compounds used in this study were purchased from Sigma–Aldrich (St. Louis, MO, USA) and were of analytical grade. The 10−1 M KCl solution, used in the preliminary studies, was prepared by dissolving a quantity of potassium chloride in ultrapure water. The 10−3 M potassium ferro/ferricyanide solution (5 × 10−4 M potassium ferrocyanide + 5 × 10−4 M potassium ferricyanide) and the 10−4 M catechol solution were prepared by dissolving substances in appropriate amounts in a 10−1 M KCl solution. The same catechol–KCl solution was used as the supporting electrolyte in the studies for the detection of PBZ. For the preparation of the 10−4 M PBZ solution, the required (calculated) amount of pure substance was dissolved in 10−1 M KCl—10−4 M catechol solution.
Electrochemical experiments were performed at 20 ± 2 °C with a Biologic Instruments SP 150 potentiostat/galvanostat (BioLogic Science Instruments, Seyssinet-Pariset, France), connected to the EC-LAB Express software Version 5.52. The experiments were performed in a 50 mL electrochemical cell (Princeton Applied Research, Oak Ridge, TN, USA) equipped with a three-electrode system: an Ag/AgCl reference electrode, a platinum counter electrode, and a screen-printed carbon working electrode modified with transitional metal particles (Ir, Pd, Pt, and Rh, used sequentially). The screen-printed carbon working electrodes used in this study are fabricated on a ceramic substrate and modified with rhodium, palladium, platinum, or iridium particles and were purchased from Metrohm DropSens (Llanera, Asturias, Spain). The K0265 Ag/AgCl Reference Electrode, Princeton Applied Research from AMETEK Scientific Instruments, was used as a reference electrode. K0266 Platinum Counter Electrode Assembly was used as a counter electrode (Princeton Applied Research from AMETEK Scientific Instruments, Oak Ridge, TN, USA).
The ultrapure water used was obtained using a Mili-Q Millipore water purification system (Bedford, MA, USA). Accurate weighing of substances was performed using an analytical scale, and an Elmasonic ultrasonic bath (Carl Roth GmbH, Karlsruhe, Germany) was used for dissolution of compounds and solution homogenization.
For the analysis of real samples, a quantity of cream containing phenylbutazone in identical concentrations (40 mg/g) was weighed. This was subjected to a sequential extraction in ethanol, using 1 mL of ethanol each time, repeating the extraction process five times. After extraction, the ethanol solution was dissolved in ultrapure water and then subjected to a sonication process for 30 min at 40 °C to facilitate dissolution. From the obtained stock solution, volumes of 50 µL were added to a volume of 50 mL of a 10−4 M catechol—10−1 M KCl solution. This solution was used for the voltammetric determination of PBZ.
The electrochemical behaviour and analytical performance of four screen-printed carbon electrodes modified with iridium, palladium, platinum, and rhodium were studied: Ir/CSPE, Pd/CSPE, Pt/CSPE, and Rh/CSPE. All electrochemical measurements were performed using cyclic voltammetry as the detection technique, a versatile technique that allows the rapid detection of active compounds from various samples.
The pharmaceutical products analyzed for the validation of the method were creams from different producers. The composition of the pharmaceutical products is included in
Table 2.
4. Conclusions
In summary, among the four electrodes analyzed in this study, the Ir/CSPE proved to be the most suitable for PBZ detection. Even in the preliminary analyses, both the Ir/CSPE and Rh/CSPE exhibited the lowest background currents, indicating their superior performance in voltammetric measurements. They also presented the smallest potential difference between the anodic and cathodic peaks, which indicates faster electron transfer kinetics compared to the other sensors analyzed. These observations highlight the advantageous properties of iridium- and rhodium-based electrodes for surface modification aimed at enhancing the kinetics and reversibility of redox processes.
Furthermore, iridium (Ir/CSPE) and rhodium (Rh/CSPE) proved to be the most efficient materials, providing an optimal balance between electron transfer kinetics and redox process reversibility. Overall, among all sensors tested, the Ir/CSPE demonstrated the largest electroactive surface area, and its roughness factor (RF) was higher than that of the remaining electrodes, confirming its superior sensitivity and efficiency in the electrochemical detection. Based on the calculated surface coverage with electroactive species, as well as the preliminary findings, the Ir/CSPE yielded the most favourable results and was selected for the calibration process. The method displayed a linear range of 0.01 to 1.00 μM, with a detection limit of 1.53 nM and a quantification limit of 5.08 nM. Moreover, analyses carried out on real pharmaceutical samples confirmed that the peak observed at 0.0 V was consistent with that obtained for the pure compound, thereby validating the electrode’s applicability for reliable phenylbutazone detection and quantification.